Here’s the latest from our Curious Dr. George! Read “High-Energy Blue Light Powers a Promising New Treatment to Destroy Cancer Cells” here. A perennial challenge in cancer treatment is figuring out how to kill tumor cells while leaving healthy cells unharmed. Our Curious Dr. George asks Stuart L. Marcus, MD, PhD, founder and Chief Science Officer at SonALAsense, how his company’s light-activated drug treatment addresses… Read more »
Here’s the latest from our Curious Dr. George! Read “Integrating AI-Generated Learning Materials into Health Professional Education” here. Artificial intelligence (A.I.) is a powerful tool that has made its way into diverse fields—and medical education is no exception. Our Curious Dr. George asks Miriam Chickering, RN, BSN, NE-BC, CEO of NextGenU.org, how the 22-year-old, U.S.-based organization she leads uses A.I. to help create free… Read more »
Here’s the latest from our Curious Dr. George! Read “How Would an Expert Manage His Own Acute Myelogenous Leukemia?” here. When facing a frightening new cancer diagnosis, some people ask their doctors, “What would you do if you were me?” Here, our Curious Dr. George asks leukemia expert Adam Asch, MD, how he would handle his own case of acute myelogenous leukemia. Dr. Asch… Read more »
Here’s the latest from our Curious Dr. George! Read “How Would an Expert Manage His Own Advanced Esophageal Cancer?” here. When facing a frightening new cancer diagnosis, some people ask their doctors, “What would you do if you were me?” Here, our Curious Dr. George asks gastrointestinal cancer expert Sarbajit Mukherjee, MD, MS, how he would handle his own case of advanced esophageal cancer.… Read more »
Cancer Commons’ most recent webinar, Recurrent Cancer: Unique Treatment Guidance After Cancer Returns, was held virtually June 14, 2023. During the presentation, Dennis Watson, VP of Business Development of Travera, provided viewers with information and updates on a cancer therapy guidance test designed to predict which cancer drugs are most likely to be effective for individual cancer patients. Travera’s unique technology now applies to many cancers… Read more »
Adrienne Nugent, PhD, has always loved a good puzzle. Growing up, she enjoyed solving math problems, and in college at Duke University, chemistry inspired her puzzle-solving passion. She continued to apply this skill as she earned her PhD in genetics and genomics, also at Duke. Since then, she has found a through-line between her love for puzzles and her love for working directly with… Read more »
Cancer Commons’ most recent webinar, A New Technology for Rapid Therapy Guidance, was held virtually December 14, 2022. This presentation and Q&A session introduced viewers to a new cancer therapy guidance test that is designed to predict which cancer drugs are most likely to be effective for individual cancer patients. Cancer Commons CEO Rebecca Driscoll introduced Clifford Reid, PhD (Founder and CEO) and Dennis Watson (VP… Read more »
We invite everyone to join us to learn about a cancer therapy guidance test designed to predict which cancer drugs are most likely to be effective for individual cancer patients. Cancer Commons is partnering with Travera with the shared goal of helping late-stage cancer patients who are running out of therapeutic options and time. A New Technology for Rapid Therapy Guidance will be held December 14,… Read more »
Cancer Commons’ most recent webinar, Tools and Strategies to Take Your Cancer Management to the Next Level, was held virtually on November 9, 2022. This dynamic one-hour session introduced participants to three passionate advocates making a difference in the lives of cancer patients and caregivers: Cancer Commons CEO Rebecca Driscoll, Courage Groups founder Mike Looney, PhD, and We’re in This Together (WiTT) CEO Rahul Mahadevan. The webinar was… Read more »
We are proud to share that this month, Commons Scientist Kaumudi Bhawe, PhD, presented a poster at the 2022 TargetCancer Foundation Think Tank on Advancing Gastroesophageal Cancer Research. The Think Tank is a unique, two-day scientific meeting addressing the challenges facing researchers and clinicians in gastroesophageal cancer. This highly interactive and discussion-based meeting is designed to promote information-sharing and idea generation in an effort… Read more »
